IMVT
Immunovant, Inc.
NASDAQ · Healthcare · Biotechnology · US
$39.51
+1.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 228.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 11.10x
- Price / sales
- 1150.23x
- Price / cash flow
- -19.70x
Enterprise value
- Enterprise value
- $7.4B
- EV / sales
- 1037.79x
- EV / EBITDA
- -13.67x
- EV / EBIT
- -13.17x
- Market cap
- $8.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026